首页> 外文OA文献 >A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel (R) + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults

【2h】

A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel (R) + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults

机译：AMA1-C1 / Alhydrogel（R）+ CPG 7909疫苗在半免疫马里成人恶性疟原虫疟疾中的安全性和免疫原性的随机对照研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sagara, Issaka; Ellis, Ruth D.; Dicko, Alassane; Niambele, Mohamed B.; Kamate, Beh; Guindo, Ousmane; Sissoko, Mahamadou S.; Fay, Michael P.; Guindo, Merepen A.; Kante, Ousmane; Saye, Renion; Miura, Kazutoyo; Long, Carole; Mullen, Gregory E. D.; Pierce, Mark; Martin, Laura B.; Rausch, Kelly; Dolo, Amagana; Diallo, Dapa A.; Miller, Louis H.; Doumbo, Ogobara K.; Mullen, Gregory;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel (R) + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults [J] . Sagara Issaka, Ellis Ruth D., Dicko Alassane, Vaccine . 2009,第52期

机译：AMA1-C1 / Alhydrogel（R）+ CPG 7909疫苗在半免疫马里成人恶性疟原虫疟疾中的安全性和免疫原性的随机对照1期研究
2. Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum : a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults [J] . Issaka Sagara, Sara A Healy, Mahamadoun H Assadou, The Lancet infectious diseases . 2018,第9期

机译：PFS25H-EPA / Alhydrogel的安全性和免疫原性，对疟原虫的传动阻断疫苗：健康玛丽安成年人的随机，双盲，比较，对照，剂量升级研究
3. Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP142-C1/Alhydrogel with and without CPG 7909 in Malaria Naïve Adults [J] . Ruth D. Ellis, Laura B. Martin, Donna Shaffer, PLoS One . 2010,第1期

机译：疟原虫成人恶性疟原虫血液阶段疫苗MSP142-C1 / Alhydrogel 1期试验
4. Immunogenicity of Malaria Vaccine Candidate-Plasmodium falciparum Merozoite Surface Protein 5 (PfMSP5) Expressed in Bacillus subtilis [C] . Chittibabu Gottimukkala, Charles Ma, Hans J. Netter International Conference on Chemical, Biological and Environmental Engineering . 2014

机译：疟疾疫苗候选疟原虫的免疫原性是恶魔植物在枯草芽孢杆菌中表达的疟原虫候选疟原虫疟原虫表面蛋白5（PFMSP5）
5. A Randomized Controlled Phase 1 Study of the Safety and Immunogenicity of the AMA1-C1/Alhydrogel® + CPG 7909 Vaccine for Plasmodium falciparum Malaria in Semi-immune Malian Adults [O] . Issaka Sagara, Ruth D. Ellis, Alassane Dicko, -1

机译：随机受控的第1期AMA1-C1 /Alhydrogel®+ CpG 7909疫苗的安全性和免疫原性用于半免疫疟原虫疟疾疟疾的疫苗在半免疫马里安成人中
6. Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria [O] . Mullen, Gregory E. D., Ellis, Ruth D., Miura, Kazutoyo, 2008

机译：AMA1-C1 / Alhydrogel加CPG 7909的1期试验：恶性疟原虫疟疾的无性血期疫苗

A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel (R) + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults

著录项

引文网络

相似文献

相关主题

期刊订阅